scholarly journals Actinobacillus suis

2020 ◽  
Author(s):  
Keyword(s):  
Actinobacillus Suis

Actinobacillus suis: Finger isolate following horse bite

1986 ◽  
Vol 8 (24) ◽  
pp. 187-188 ◽  
Author(s):  
Anne Ruddy ◽  
Joan Hughes ◽  
Paul Bourbeau
Keyword(s):  
Actinobacillus Suis

scholarly journals Perlakuan Rizobakteri Pemacu Pertumbuhan Tanaman (RPPT) dengan Beberapa Tingkat Kerapatan Inokulum Rizobakteri Terhadap Viabilitas dan Vigor Benih Cabai Merah Kadaluarsa (Capsicum annuum L.)

2020 ◽  
Vol 4 (1) ◽  
pp. 229-238
Author(s):  
Dayang Rahmanita Simanjuntak ◽  
Halimursyadah Halimursyadah ◽  
Syamsuddin Syamsuddin
Keyword(s):  
Plant Growth ◽  
Capsicum Annuum ◽  
Seed Treatment ◽  
Dry Weight ◽  
Plant Growth Promoting Rhizobacteria ◽  
Seed Vigor ◽  
Inoculum Density ◽  
Plant Growth Promoting ◽  
Actinobacillus Suis ◽  
Growth Promoting

Abstrak. Biological seed treatment merupakan salah satu perlakuan benih menggunakan mikroorganisme seperti rizobakteri pemacu pertumbuhan tanaman (RPPT). Penelitian ini bertujuan untuk mengetahui jenis rizobakteri dan kerapatan inokulum yang dapat meningkatkan viabilitas dan vigor benih cabai kadaluarsa. Penelitian ini menggunakan Rancangan Acak Lengkap (RAL) pola faktorial dengan 2 faktor dan 3 ulangan. Faktor pertama adalah jenis rizobakteri (R) terdiri atas lima taraf yaitu R1: Necercia sp; R2:Bacillus polymixa; R3: Actinobacillus suis; R4: Azotobacter sp; R5: Pseudomonas capacia. Faktor kedua adalah kerapatan inokulum rizobakteri terdiri dari tiga taraf yaitu K1: 107 cfu/ml; K2: 108 cfu/ml; K3: 109 cfu/ml. Hasil penelitian ini menunjukkan bahwa perlakuan benih menggunakan rizobakteri jenis Necercia sp dengan kerapatan inokulum 108 cfu/ml nyata meningkatkan vigor benih pada tolok ukur  indeks vigor yaitu 40% dan Pseudomonas capacia dengan kerapatan inokulum 109 cfu/ml juga merupakan kombinasi perlakuan terbaik dalam meningkatkan berat kering kecambah normal yaitu 69,33 mg.Treatment Of Plant Growth Promoting Rhizobacteria (PGPR)With Multiple Levels of Rhizobacteria Inoculum Density On Viability and Vigor Of Expired Red Chilli Seeds (Capsicum annuum L.Abstract. Biological seed treatment is one of the seed treatment using microorganisms such as plant growth-promoting rhizobacteria (PGPR). This study aims to determine the type of rhizobacteria and inoculum density that can increase the viability and vigor of expired chili seeds. This research uses Completely Randomized Design (CRD) factorial pattern with 2 factors and 3 replications. The first factor is the type of rhizobacteria (R) consists of five levels, namely R1: Necercia sp; R2: Bacillus polymixa; R3: Actinobacillus suis; R4: Azotobacter sp; R5: Pseudomonas capacia. The second factor is the density of rhizobacteria inoculum consisting of three levels namely K1: 107 cfu/ml; K2: 108 cfu/ml; K3: 109 cfu/ml. The results of this study showed that the seed treatment using the Necercia sp-type rizobacteria with 108 cfu/ml inoculum density significantly increased the seed vigor on the vigor index benchmark of 40% and Pseudomonas capacia with 109cfu/ml inoculum density was also the best treatment combination in increasing dry weight normal sprout is 69,33 mg. 

Actinobacillus suis infection after a pig bite

The Lancet ◽  
1996 ◽  
Vol 348 (9031) ◽  
pp. 888 ◽  
Author(s):  
F Escande ◽  
A Bailly ◽  
S Bone ◽  
J Lemozy
Keyword(s):  
Actinobacillus Suis

Isolation of Actinobacillus suis from a Canada Goose (Branta canadensis)

1987 ◽  
Vol 23 (3) ◽  
pp. 483-484 ◽  
Author(s):  
R. L Maddux ◽  
M. M. Chengappa ◽  
B. G. McLaughlin
Keyword(s):  
Branta Canadensis ◽  
Canada Goose ◽  
Actinobacillus Suis

Characterization of colonization-deficient mutants of Actinobacillus suis

2010 ◽  
Vol 140 (1-2) ◽  
pp. 122-130 ◽  
Author(s):  
S. Ojha ◽  
S. Lacouture ◽  
M. Gottschalk ◽  
J.I. MacInnes
Keyword(s):  
Actinobacillus Suis

scholarly journals First Human Case of Meningitis and Sepsis in a Child Caused by Actinobacillus suis or Actinobacillus equuli

2015 ◽  
Vol 53 (6) ◽  
pp. 1990-1992 ◽  
Author(s):  
Carlotta Montagnani ◽  
Patrizia Pecile ◽  
Maria Moriondo ◽  
Patrizia Petricci ◽  
Sabrina Becciani ◽  
...  
Keyword(s):  
Opportunistic Pathogen ◽  
Human Case ◽  
Laser Desorption Ionization ◽  
Pcr Assay ◽  
Ionization Time ◽  
Content Type ◽  
Flight Mass Spectrometry ◽  
Source Of Infection ◽  
Actinobacillus Suis ◽  
Previous Visit

We report the first human case of meningitis and sepsis caused in a child byActinobacillus suisorA. equuli, a common opportunistic pathogen of swine or horses, respectively. Identification was performed by matrix-assisted laser desorption ionization–time of flight mass spectrometry and real-time PCR assay. A previous visit to a farm was suspected as the source of infection.

Isolation of Actinobacillus Suis from a Colt

1978 ◽  
Vol 134 (2) ◽  
pp. 122-127 ◽  
Author(s):  
J.F. Harbourne ◽  
N.S. Mair ◽  
S.G. Keighley
Keyword(s):  
Actinobacillus Suis

scholarly journals Efficacy of bacterial vaccines to prevent respiratory disease in swine: a systematic review and network meta-analysis

2019 ◽  
Vol 20 (2) ◽  
pp. 274-290 ◽  
Author(s):  
Jan M. Sargeant ◽  
Bhumika Deb ◽  
Michele D. Bergevin ◽  
Katheryn Churchill ◽  
Kaitlyn Dawkins ◽  
...  
Keyword(s):  
Systematic Review ◽  
Respiratory Disease ◽  
Pasteurella Multocida ◽  
Meta Analysis ◽  
Grey Literature ◽  
Antibiotic Use ◽  
Bordetella Bronchiseptica ◽  
Comparative Efficacy ◽  
Lung Lesions ◽  
Actinobacillus Suis

AbstractA systematic review and network meta-analysis (MA) was conducted to address the question, ‘What is the efficacy of bacterial vaccines to prevent respiratory disease in swine?’ Four electronic databases and the grey literature were searched to identify clinical trials in healthy swine where at least one intervention arm was a commercially available vaccine for one or more bacterial pathogens associated with respiratory disease in swine, including Mycoplasma hyopneumoniae, Actinobacillus pleuropneumonia, Actinobacillus suis, Bordetella bronchiseptica, Pasteurella multocida, Stretococcus suis, Haemophils parasuis, and Mycoplasma hyorhinis. To be eligible, trials had to measure at least one of the following outcomes: incidence of clinical morbidity, mortality, lung lesions, or total antibiotic use. There were 179 eligible trials identified in 146 publications. Network MA was undertaken for morbidity, mortality, and the presence or absence of non-specific lung lesions. However, there was not a sufficient body of research evaluating the same interventions and outcomes to allow a meaningful synthesis of the comparative efficacy of the vaccines. To build this body of research, additional rigor in trial design and analysis, and detailed reporting of trial methods and results are warranted.

Sign in / Sign up

Export Citation Format

Share Document